This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

CeriBell, Inc.
2/24/2026
Hello and welcome to the Cerebral Q4 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. And if you would like to withdraw your question, press star one again. Thank you. I will now turn the call over to Brian Johnston, Investor Relations. Brian, you may begin.
Good afternoon, and thank you all for participating in today's call. Joining me from Sarah Bell are Jane Chow, co-founder and chief executive officer, and Scott Blumberg, chief financial officer. Earlier today, Sarah Bell issued a press release announcing financial results for the quarter and year ended December 31st, 2025. A copy of the press release is available on the investor relations section of the company's website. Before we begin, I'd like to remind you that management will make remarks during this call that include forward-looking statements within the meaning of federal securities laws, and that these are being made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the risk factors section of our public filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q filed with the SEC on November 4th, 2025. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, February 24th, 2026. TheraBell disclaims any intention or obligation except as required by law to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.
And with that, I'll turn the call over to Jane.
You're reading a preview of the CBLL Q4 2025 earnings call.
Free account.